JMDC Inc
TSE:4483

Watchlist Manager
JMDC Inc Logo
JMDC Inc
TSE:4483
Watchlist
Price: 3 864 JPY -1.1% Market Closed
Market Cap: 252.6B JPY
Have any thoughts about
JMDC Inc?
Write Note

JMDC Inc
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

JMDC Inc
Depreciation & Amortization Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
JMDC Inc
TSE:4483
Depreciation & Amortization
ÂĄ2.5B
CAGR 3-Years
23%
CAGR 5-Years
24%
CAGR 10-Years
N/A
M3 Inc
TSE:2413
Depreciation & Amortization
ÂĄ9.8B
CAGR 3-Years
18%
CAGR 5-Years
28%
CAGR 10-Years
34%
EM Systems Co Ltd
TSE:4820
Depreciation & Amortization
ÂĄ1.7B
CAGR 3-Years
13%
CAGR 5-Years
24%
CAGR 10-Years
9%
S
Software Service Inc
TSE:3733
Depreciation & Amortization
ÂĄ618.2m
CAGR 3-Years
36%
CAGR 5-Years
17%
CAGR 10-Years
20%
Medley Inc
TSE:4480
Depreciation & Amortization
ÂĄ659m
CAGR 3-Years
65%
CAGR 5-Years
66%
CAGR 10-Years
N/A
e
eWeLL Co Ltd
TSE:5038
Depreciation & Amortization
ÂĄ59.1m
CAGR 3-Years
111%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

JMDC Inc
Glance View

Market Cap
252.5B JPY
Industry
Health Care

Amidst the complex intersection of healthcare and technology, JMDC Inc. has carved a unique niche by harnessing the power of big data to improve healthcare outcomes and efficiency. Founded in Japan, the company stands as a beacon in the health informatics sector, meticulously collecting and analyzing health-related data drawn from a variety of sources, including medical claims, health screenings, and electronic health records. By transforming this extensive data trove into actionable insights, JMDC offers healthcare providers, pharmaceutical companies, and insurance firms the analytics they need to make informed decisions. Key to JMDC's operation is its commitment to safeguarding patient anonymity while extracting valuable insights that can streamline healthcare delivery, enhance pharmaceutical research, and optimize insurance underwriting. JMDC's revenue model hinges on the sale of its aggregated data and analytics solutions to a vast array of stakeholders in the medical field. Pharmaceutical companies, eager to understand drug efficacy and patient demographics better, turn to JMDC for data-driven insights that can influence drug development and marketing strategies. Insurance companies leverage JMDC's data to refine their offerings and better assess risk, ensuring competitive pricing models and improved customer satisfaction. Moreover, healthcare providers utilize this analytics backbone to enhance operational efficiency and improve patient care outcomes. Through licensing agreements and subscription-based services, JMDC effectively monetizes its data resources, achieving sustained growth in an industry that increasingly values the marriage of technology and healthcare.

Intrinsic Value
3 587.97 JPY
Overvaluation 7%
Intrinsic Value
Price

See Also

What is JMDC Inc's Depreciation & Amortization?
Depreciation & Amortization
2.5B JPY

Based on the financial report for Sep 30, 2024, JMDC Inc's Depreciation & Amortization amounts to 2.5B JPY.

What is JMDC Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
24%

Over the last year, the Depreciation & Amortization growth was 16%. The average annual Depreciation & Amortization growth rates for JMDC Inc have been 23% over the past three years , 24% over the past five years .

Back to Top